KOD - Kodiak Sciences Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Palo Alto,
United States
Type: Equity
KOD price evolution
KOD
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $291.83 | $351.99 | $384.99 | $322.94 |
| Short term investments | $104.58 | |||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $289.31 | $350.93 | $386.96 | $431.12 |
| Long term investments | ||||
| Property, plant & equipment | $175.02 | $181.67 | $187.37 | $193.69 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $190.06 | $196.72 | $202.7 | $209.22 |
| Total investments | $104.58 | |||
| Total assets | $479.37 | $547.65 | $589.66 | $640.33 |
| Current liabilities | ||||
| Accounts payable | $13.61 | $38.59 | $12.35 | $6.26 |
| Deferred revenue | ||||
| Short long term debt | $9.77 | $9.02 | $7.85 | $7.94 |
| Total current liabilities | $41.73 | $70.77 | $74.24 | $68.94 |
| Long term debt | $71.86 | $74.46 | $76.94 | $78.81 |
| Total noncurrent liabilities | $171.86 | $174.46 | $176.94 | $178.81 |
| Total debt | $81.63 | $83.48 | $84.79 | $86.75 |
| Total liabilities | $213.59 | $245.24 | $251.18 | $247.75 |
| Shareholders' equity | ||||
| Retained earnings | -$1152.53 | -$1093.02 | -$1043.01 | -$962.82 |
| Other shareholder equity | -$0.1 | |||
| Total shareholder equity | $265.78 | $302.42 | $338.48 | $392.59 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $291.83 | $196.76 | $737.83 | $950.72 |
| Short term investments | $288.5 | $24.58 | ||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $289.31 | $486 | $734.81 | $972 |
| Long term investments | ||||
| Property, plant & equipment | $175.02 | $115.75 | $108.07 | $78.81 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $190.06 | $180.62 | $169.41 | $95.34 |
| Total investments | $288.5 | $24.58 | ||
| Total assets | $479.37 | $666.63 | $904.22 | $1067.35 |
| Current liabilities | ||||
| Accounts payable | $13.61 | $9.13 | $12.43 | $8.65 |
| Deferred revenue | ||||
| Short long term debt | $9.77 | $9.93 | $3.93 | $2.37 |
| Total current liabilities | $41.73 | $52.5 | $64.68 | $31.42 |
| Long term debt | $71.86 | $77.81 | $76.06 | $75.03 |
| Total noncurrent liabilities | $171.86 | $177.97 | $176.22 | $175.17 |
| Total debt | $81.63 | $87.73 | $80 | $77.4 |
| Total liabilities | $213.59 | $230.46 | $240.9 | $206.6 |
| Shareholders' equity | ||||
| Retained earnings | -$1152.53 | -$892.04 | -$558.22 | -$291.23 |
| Other shareholder equity | -$1.31 | $0.05 | ||
| Total shareholder equity | $265.78 | $436.17 | $663.32 | $860.75 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $46.63 | $36.19 | $66.96 | $56.52 |
| Selling, general & administrative | $16.75 | $18.31 | $17.87 | $18.09 |
| Total operating expenses | $63.37 | $54.5 | $84.83 | $74.61 |
| Operating income | -$63.37 | -$54.5 | -$84.83 | -$74.61 |
| Income from continuing operations | ||||
| EBIT | -$59.52 | -$50 | -$80.18 | -$70.78 |
| Income tax expense | ||||
| Interest expense | $0.01 | $0 | $0 | |
| Net income | ||||
| Net income | -$59.52 | -$50.01 | -$80.19 | -$70.78 |
| Income (for common shares) | -$59.52 | -$50.01 | -$80.19 | -$70.78 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $206.3 | $267.59 | $217.34 | $107.39 |
| Selling, general & administrative | $71.02 | $73.79 | $49.71 | $28.62 |
| Total operating expenses | $277.32 | $341.38 | $267.05 | $136.01 |
| Operating income | -$277.32 | -$341.38 | -$267.05 | -$136.01 |
| Income from continuing operations | ||||
| EBIT | -$260.48 | -$333.81 | -$266.97 | -$133.07 |
| Income tax expense | ||||
| Interest expense | $0.01 | $0.02 | $0.02 | $0.03 |
| Net income | ||||
| Net income | -$260.49 | -$333.82 | -$266.99 | -$133.1 |
| Income (for common shares) | -$260.49 | -$333.82 | -$266.99 | -$133.1 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$59.52 | -$50.01 | -$80.19 | -$70.78 |
| Operating activities | ||||
| Depreciation | $6.66 | $6.97 | $6.66 | $5.66 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $22.83 | $13.95 | $25.8 | $25.98 |
| Total cash flows from operations | -$32.24 | -$32.76 | -$41.96 | -$47.22 |
| Investing activities | ||||
| Capital expenditures | -$27.48 | -$0.23 | -$1.47 | -$12.25 |
| Investments | $105 | $185.65 | ||
| Total cash flows from investing | -$27.8 | -$0.23 | $103.84 | $173.41 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.05 | $0.18 | $0.01 | |
| Net borrowings | ||||
| Total cash flows from financing | -$0.12 | -$0.01 | $0.17 | -$0 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$60.16 | -$33 | $62.05 | $126.18 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$260.49 | -$333.82 | -$266.99 | -$133.1 |
| Operating activities | ||||
| Depreciation | $25.95 | $11 | $8.71 | $4.21 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $88.56 | $106.03 | $61.38 | $30.67 |
| Total cash flows from operations | -$154.18 | -$206.46 | -$182.27 | -$83.43 |
| Investing activities | ||||
| Capital expenditures | -$41.43 | -$47.36 | -$63.3 | -$7 |
| Investments | $290.65 | -$289.77 | $24.5 | $111.83 |
| Total cash flows from investing | $249.23 | -$336.51 | -$38.8 | $104.83 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.24 | $1.94 | $8.23 | $617.78 |
| Net borrowings | -$0.01 | |||
| Total cash flows from financing | $0.03 | $1.9 | $8.18 | $717.38 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $95.07 | -$541.08 | -$212.89 | $738.78 |
News
Fundamentals
| Market cap | $182.20M |
|---|---|
| Enterprise value | -$27.99M |
| Shares outstanding | 52.51M |
| Revenue | $0.00 |
|---|---|
| EBITDA | -$234.53M |
| EBIT | -$260.48M |
| Net Income | -$260.49M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | -0.70 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | 0.12 |
| EV/EBIT | 0.11 |
| P/S ratio | N/A |
| P/B ratio | 0.69 |
| Book/Share | 5.06 |
| Cash/Share | 5.56 |
| EPS | -$4.96 |
|---|---|
| ROA | -46.17% |
| ROE | -80.20% |
| Debt/Equity | 0.80 |
|---|---|
| Net debt/EBITDA | 0.33 |
| Current ratio | 6.93 |
| Quick ratio | 6.93 |